Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
about
Soft tissue sarcoma nomograms and their incorporation into practice.Tumor macroenvironment and metabolism.Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsRisk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma.Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisC-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell CarcinomaPrognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-AnalysisPrognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomyThe Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma.A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung CancerPrognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.Immune Therapy for Sarcomas.The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.Clinical outcomes in patients with advanced EGFR-mutated non-small cell lung cancer in South Western Sydney Local Health District.A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal CancerInfiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas.A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities.The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma.The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma.
P2860
Q30234500-CB23A475-00DF-4C38-8530-945DCC2E8A09Q33574461-C424338E-E2F9-4198-9209-A9461576D359Q33589014-A3CA4420-4048-4B41-B2C8-9C0D921A8774Q33613591-CCC11E8C-CA01-4D1C-87C4-5EA7F3882D24Q33627283-AD4907BD-26A4-4626-8487-0694F748A47EQ33798673-088B5916-8209-47C7-819C-1E82FCC35946Q33829684-2D613F1E-72D8-41B8-8C4B-7200DD0716C9Q33877471-8C094A4C-E4EF-42AE-9F1C-2ADEDA144820Q34160362-6FAD6BC9-18E4-4912-A416-0389D9DAEF6FQ35072434-8E45D88E-103F-4AD4-AC07-619D1B06202FQ35163616-C745B357-9072-4D1F-8078-92695A18A631Q35738934-DEC92D44-65ED-484A-8854-8EB22D59BFE7Q35781911-6432FEDB-5E43-4B33-8228-EFFB331F581BQ36079922-E6FABA2F-C429-4B2F-B9CC-747022B6E6CFQ36392831-CB9E6229-F156-4D66-B84A-F5F12A0C0426Q37221912-EFD32743-B3A0-4242-854B-E586F11918C0Q37738071-B202455F-54D8-4ED1-AD55-3636E65FA674Q38719404-9B130B2D-A254-4A22-9606-99020E759CE7Q38742533-D9B5A549-685A-48AB-8860-551B580C7841Q38980174-92D26C6B-19F0-4E7E-B2A2-005595D8EB55Q39457284-1F034DFD-E12F-4F3A-9A26-B4E9BB323B88Q40766189-0A47BABB-0643-4777-B8B7-05C12A6DC15CQ40979708-611E6AEB-3D62-4609-83DA-5CD03DC520BEQ41072346-620B35E7-80A5-4294-9608-9BF6393029BEQ41461941-93262030-DB48-4C7C-82A9-A163C067CBA6Q41496658-E54997B7-4489-47C5-8F24-9DD5D14AADFFQ41550528-7B31FEC0-0861-42B6-A6C8-72FEF912C2CFQ42378704-ED059388-E3AC-4DCB-A8AF-8A4651F8AE9FQ44301485-64327201-E05D-47D1-88BA-BC5BE96068D8Q47140574-A0971ED2-6ACD-423C-B60F-E839F0B5BD24Q51030063-C19D09C8-F89C-4964-8089-ABB0C78D83F7Q51071190-123971C0-70EE-46D6-B8CC-0B0E53284F4BQ51737223-1910E3A3-A201-4F53-B330-FED5823DBDEE
P2860
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of the prognostic r ...... n soft-tissue sarcoma patients
@en
Validation of the prognostic r ...... soft-tissue sarcoma patients.
@nl
type
label
Validation of the prognostic r ...... n soft-tissue sarcoma patients
@en
Validation of the prognostic r ...... soft-tissue sarcoma patients.
@nl
prefLabel
Validation of the prognostic r ...... n soft-tissue sarcoma patients
@en
Validation of the prognostic r ...... soft-tissue sarcoma patients.
@nl
P2093
P2860
P356
P1476
Validation of the prognostic r ...... n soft-tissue sarcoma patients
@en
P2093
A Leithner
B Liegl-Atzwanger
G Absenger
H Samonigg
J Szkandera
T Stojakovic
P2860
P2888
P304
P356
10.1038/BJC.2013.595
P407
P577
2013-10-01T00:00:00Z